Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Rocket Pharmaceuticals highlights FDA-aligned Phase 2 for RP-A501
Rocket Pharmaceuticals highlighted an FDA-aligned pivotal Phase 2 trial and updated clinical findings for RP-A501 after a Danon disease investor webinar.
Rocket Pharmaceuticals highlights FDA-aligned RP-A501 Phase 2 results
Rocket Pharmaceuticals said it highlighted key findings and development milestones for RP-A501 from its FDA-aligned pivotal Phase 2 program during an Oct. 6 Danon disease investor webinar.